Cargando…

Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation

Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Dong Jin, Trick, Alexander Y., Hsieh, Yu-Hsiang, Thomas, David L., Wang, Tza-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023859/
https://www.ncbi.nlm.nih.gov/pubmed/29955160
http://dx.doi.org/10.1038/s41598-018-28124-3
_version_ 1783335939631742976
author Shin, Dong Jin
Trick, Alexander Y.
Hsieh, Yu-Hsiang
Thomas, David L.
Wang, Tza-Huei
author_facet Shin, Dong Jin
Trick, Alexander Y.
Hsieh, Yu-Hsiang
Thomas, David L.
Wang, Tza-Huei
author_sort Shin, Dong Jin
collection PubMed
description Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required number of visits to the clinic and improve patient retention for proper treatment. Here we present a droplet magnetofluidic (DM) platform, which leverages functionalized magnetic particles to miniaturize and automate laboratory assays for use in the clinic at the POC. Our novel thermoformed disposable cartridge coupled to a portable multiaxial magnetofluidic instrument enables real-time PCR assays for quantitative and sensitive detection of nucleic acids from crude biosamples. Instead of laborious benchtop sample purification techniques followed by elution and spiking into PCR buffer, the user simply injects the biosample of interest into a cartridge with magnetic particles and loads the cartridge into the instrument. We demonstrate the utility of our platform with hepatitis C virus (HCV) RNA viral load quantitation from blood serum in approximately 1 hour. Clinical serum samples (n = 18) were directly processed on cartridges with no false positives and a limit of detection of 45 IU per 10 µl sample injection.
format Online
Article
Text
id pubmed-6023859
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60238592018-07-06 Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation Shin, Dong Jin Trick, Alexander Y. Hsieh, Yu-Hsiang Thomas, David L. Wang, Tza-Huei Sci Rep Article Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required number of visits to the clinic and improve patient retention for proper treatment. Here we present a droplet magnetofluidic (DM) platform, which leverages functionalized magnetic particles to miniaturize and automate laboratory assays for use in the clinic at the POC. Our novel thermoformed disposable cartridge coupled to a portable multiaxial magnetofluidic instrument enables real-time PCR assays for quantitative and sensitive detection of nucleic acids from crude biosamples. Instead of laborious benchtop sample purification techniques followed by elution and spiking into PCR buffer, the user simply injects the biosample of interest into a cartridge with magnetic particles and loads the cartridge into the instrument. We demonstrate the utility of our platform with hepatitis C virus (HCV) RNA viral load quantitation from blood serum in approximately 1 hour. Clinical serum samples (n = 18) were directly processed on cartridges with no false positives and a limit of detection of 45 IU per 10 µl sample injection. Nature Publishing Group UK 2018-06-28 /pmc/articles/PMC6023859/ /pubmed/29955160 http://dx.doi.org/10.1038/s41598-018-28124-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Shin, Dong Jin
Trick, Alexander Y.
Hsieh, Yu-Hsiang
Thomas, David L.
Wang, Tza-Huei
Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title_full Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title_fullStr Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title_full_unstemmed Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title_short Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
title_sort sample-to-answer droplet magnetofluidic platform for point-of-care hepatitis c viral load quantitation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023859/
https://www.ncbi.nlm.nih.gov/pubmed/29955160
http://dx.doi.org/10.1038/s41598-018-28124-3
work_keys_str_mv AT shindongjin sampletoanswerdropletmagnetofluidicplatformforpointofcarehepatitiscviralloadquantitation
AT trickalexandery sampletoanswerdropletmagnetofluidicplatformforpointofcarehepatitiscviralloadquantitation
AT hsiehyuhsiang sampletoanswerdropletmagnetofluidicplatformforpointofcarehepatitiscviralloadquantitation
AT thomasdavidl sampletoanswerdropletmagnetofluidicplatformforpointofcarehepatitiscviralloadquantitation
AT wangtzahuei sampletoanswerdropletmagnetofluidicplatformforpointofcarehepatitiscviralloadquantitation